Related Experiment Video
Updated: Aug 16, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention
1Department of Internal Medicine II, Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany. Klaus.Parhofer@med.uni-muenchen.de
Insights
Dyslipoproteinemias, like high LDL-cholesterol and low HDL-cholesterol, are key to atherosclerosis. While LDL reduction is primary, optimizing all lipid parameters, including HDL, may benefit many patients.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Atherosclerosis Research
Background:
- Dyslipoproteinemias, including elevated LDL-cholesterol, reduced HDL-cholesterol, elevated triglycerides, and elevated lipoprotein(a), are central to atherosclerosis development.
- Elevated LDL (low-density lipoprotein) is pro-atherogenic, promoting oxidative and inflammatory processes in the arterial wall.
- HDL (high-density lipoprotein) is anti-atherogenic, facilitating cholesterol efflux, modulating atherogenic lipoproteins, and supporting endothelial function.
Purpose of the Study:
- To review the role of various dyslipoproteinemias in atherosclerosis.
- To discuss the therapeutic strategies focusing on LDL reduction and HDL elevation.
- To highlight the potential benefits of combination therapy for optimizing lipid profiles.
Main Methods:
- Literature review of dyslipoproteinemias and their role in atherosclerosis.
- Analysis of current therapeutic approaches targeting lipid parameters.
- Evaluation of the impact of LDL reduction and HDL elevation on cardiovascular outcomes.
Main Results:
- Elevated LDL is pro-atherogenic, while HDL is anti-atherogenic.
- Current therapy prioritizes LDL reduction, with less focus on HDL elevation.
- Fibrates and nicotinic acid/niacin effectively increase HDL-cholesterol and have shown benefits in large studies.
Conclusions:
- Statin-based LDL reduction is the cornerstone for patients with established atherosclerosis or high risk.
- Combination therapy targeting multiple lipid parameters may offer additional benefits.
- Development of new HDL-raising drugs is ongoing, expanding therapeutic options.
Abstract:
Dyslipoproteinemias such as elevated LDL-cholesterol, reduced HDL-cholesterol, elevated triglycerides and elevated lipoprotein(a) play a central role in atherosclerosis. An elevated LDL concentration is pro-atherogenic because LDL are intimately linked to oxidative and inflammatory processes in the arterial wall. HDL on the other hand are anti-atherogenic because they mediate cholesterol efflux from the arterial wall, modulate the metabolism of atherogenic lipoproteins, and directly affect endothelial function. The current therapeutic focus is on LDL reduction and much less on HDL elevation, although fibrates and particularly nicotinic-acid/niacin are potent drugs to increase HDL-cholesterol and although both groups of drugs have been proven beneficial in large end-point studies. Furthermore, new HDL raising drugs are being developed. In patients with established atherosclerosis or at high risk for atherosclerosis statin-based LDL reduction will remain the cornerstone of lipid therapy, but many patients may benefit from combination therapy aiming at optimizing all lipid parameters.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...